Your browser doesn't support javascript.
loading
The representation of public values in health technology assessment to inform funding decisions: the case of Australia's national funding bodies.
Haji Ali Afzali, Hossein; Street, Jackie; Merlin, Tracy; Karnon, Jonathan.
Afiliación
  • Haji Ali Afzali H; College of Medicine and Public Health, Flinders University, Bedford Park, South Australia 5042, Australia.
  • Street J; School of Health and Society, University of Wollongong, Wollongong, New South Wales 2522, Australia.
  • Merlin T; School of Public Health, The University of Adelaide, Adelaide, South Australia 5005, Australia.
  • Karnon J; College of Medicine and Public Health, Flinders University, Bedford Park, South Australia 5042, Australia.
Int J Technol Assess Health Care ; 37: e22, 2021 Jan 18.
Article en En | MEDLINE | ID: mdl-33455592
Over the past few years, there has been an increasing recognition of the value of public involvement in health technology assessment (HTA) to ensure the legitimacy and fairness of public funding decisions [Street J, Stafinski T, Lopes E, Menon D. Defining the role of the public in Health Technology Assessment (HTA) and HTA-informed decision-making processes. Int J Technol Assess Health Care. 2020;36:87-95]. However, important challenges remain, in particular, how to reorient HTA to reflect public priorities. In a recent international survey of thirty HTA agencies conducted by the International Network of Agencies for HTA (INAHTA), public engagement in HTA was listed as one of the "Top 10" challenges for HTA agencies [O'Rourke B, Werko SS, Merlin T, Huang LY, Schuller T. The "Top 10" challenges for health technology assessment: INAHTA viewpoint. Int J Technol Assess. 2020;36:1-4].Historically, Australia has been at the forefront of the application of HTA for assessing the effectiveness and cost-effectiveness of new health technologies to inform public funding decisions. However, current HTA processes in Australia lack meaningful public inputs. Using Australia as an example, we describe this important limitation and discuss the potential impact of this gap on the health system and future directions.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Evaluación de la Tecnología Biomédica / Financiación del Capital / Toma de Decisiones Tipo de estudio: Health_technology_assessment / Prognostic_studies Aspecto: Patient_preference País/Región como asunto: Oceania Idioma: En Revista: Int J Technol Assess Health Care Asunto de la revista: PESQUISA EM SERVICOS DE SAUDE Año: 2021 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Evaluación de la Tecnología Biomédica / Financiación del Capital / Toma de Decisiones Tipo de estudio: Health_technology_assessment / Prognostic_studies Aspecto: Patient_preference País/Región como asunto: Oceania Idioma: En Revista: Int J Technol Assess Health Care Asunto de la revista: PESQUISA EM SERVICOS DE SAUDE Año: 2021 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Reino Unido